Proteomics for biodefense applications: progress and opportunities
- PMID: 15892565
- PMCID: PMC7105753
- DOI: 10.1586/14789450.2.2.203
Proteomics for biodefense applications: progress and opportunities
Abstract
The increasing threat of bioterrorism and continued emergence of new infectious diseases has driven a major resurgence in biomedical research efforts to develop improved treatments, diagnostics and vaccines, as well as increase the fundamental understanding of the host immune response to infectious agents. The availability of multiple mass spectrometry platforms combined with multidimensional separation technologies and microbial genomic databases provides an unprecedented opportunity to develop these much needed resources. An overview of current proteomic strategies applied to microbes and viruses considered potential bioterrorism agents is presented. The emerging area of immunoproteomics as applied to the development of new vaccine targets is also summarized. These powerful research approaches can generate a multitude of potential new protein targets; however, translating these proteomic discoveries to useful counter-bioterrorism products will require large collaborative research efforts across multiple basic science and clinical disciplines. A translational proteomic research paradigm illustrating this approach using influenza virus as an example is discussed.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - English RD, Warscheid B, Fenselau C, Cotter RJ. Bacillus spore identification via proteolytic peptide mapping with a miniaturized MALDI TOF mass spectrometer. Anal. Chem. 75(24), 6886–6893 (2003). - PubMed
 
- 
    - Cordwell SJ, Nouwens AS, Walsh BJ. Comparative proteomics of bacterial pathogens. Proteomics 1(4), 461–472 (2001). - PubMed
 
- 
    - Klade CS. Proteomics approaches towards antigen discovery and vaccine development. Curr. Opin. Mol. Ther. 4(3), 216–223 (2002). - PubMed
 
- 
    - Elhanany E, Barak R, Fisher M, Kobiler D, Altboum Z. Detection of specific Bacillus anthracis spore biomarkers by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 15(22), 2110–2116 (2001). - PubMed
 
Websites
- 
    - NIAID Biodefense Research www2.niaid.nih.gov/biodefense/research/ strat_plan.htm (Viewed March 2005)
 
- 
    - NIAID Category A, B and C Priority Pathogens www2.niaid.nih.gov/Biodefense/bandc_ priority.htm (Viewed March 2005)
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        